江苏省成人非酒精性脂肪肝患者早期肾损伤状况及影响因素分析

肝脏 ›› 2019, Vol. 24 ›› Issue (12): 1425-1426.

江苏省成人非酒精性脂肪肝患者早期肾损伤状况及影响因素分析

彭姗姗, 钟艳丹, 俞海英

210003 南京中医药大学附属南京医院(南京市第二医院) 肝病免疫科

收稿日期:2019-04-03 发布日期:2020-03-28
通讯作者: 俞海英,Email: yuhaiying90@163.com

Received:2019-04-03 Published:2020-03-28

摘要/Abstract

摘要： 目的研究成人非酒精性脂肪肝(NAFLD)对早期肾损伤和慢性肾脏病的影响。方法以南京市第二医院收治的NAFLD患者和体检中心人员作为调查分析对象进行分组分析,对两组人群进行对比,通过logistic单因素和多因素分析探讨NAFLD与早期肾损伤的关联。结果单因素分析中,年龄、NAFLD、BMI等因素对早期肾损伤的影响有统计学意义,多因素分析显示,在调整了混杂因素之后,OR值为1.17(95%CI:1.05~1.31, P<0.05)。结论 NAFLD是早期肾损伤的独立危险因素。

彭姗姗, 钟艳丹, 俞海英. 江苏省成人非酒精性脂肪肝患者早期肾损伤状况及影响因素分析[J]. 肝脏, 2019, 24(12): 1425-1426.

参考文献

[1] Machado MV, Goncalves S, Carepa F, et al. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. Liver Int, 2012,32:241-248.
[2] 荀运浩, 施军平, 胡晨波, 等. 血清AST水平与非酒精性脂肪性肝病的进展性肝纤维化有关. 肝脏, 2010,15:160-163.
[3] Ah-Leum A, Jae-Kyung C, Mi-Na K, et al. Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older. Korean J Fam Med, 2013,34:199-205.
[4] 申振伟, 季晓康, 王庆莲, 等. 非酒精性脂肪肝与慢性肾脏病关系的回顾性队列研究. 山东大学学报:医学版, 2016,54:43-49.
[5] Hwang SJ, Lin MY, Chen HC. Prevalence of chronic kidney disease in China. Lancet, 2012,380:214.
[6] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版). 现代医药卫生, 2010,18:167-170.
[7] Xia MF, Lin HD, Li XM, et al. Renal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middle-aged and elderly Chinese population. Clin Exp Pharmacol Physiol, 2012,39:930-937.
[8] Li G, Shi W, Hug H, et al. Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population. Biochem Med (Zagreb), 2012,22:92-99.
[9] Blagg CR. Chronic kidney disease is a growing worldwide public health problem. Preface. Hemodial Int, 2011,15:303-305.
[10] Machado MV, Goncalves S, Carepa F, et al. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. Liver Int, 2012,32:241-248.
[11] Targher G, Chonchol M, Zoppini G, et al. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol, 2011,54:1020-1029.
[12] 王海军, 王炜城, 高喜玲. 非酒精性脂肪肝患者新发2型糖尿病的影响因素分析. 肝脏, 2016,21:846-849.
[13] Schuppan D, Schattenberg JM. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol, 2013,28:68-76.
[14] Luef G, Rauchenzauner M, Waldmann M, et al. Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. Epilepsy Res, 2009,86:42-47.
[15] Lim CC, Teo BW, Tai ES, et al. Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults. PLoS One, 2015,10:e122009.